Glickman Mark A's Form 4 filing
TherapeuticsMD, Inc. (TXMD) · filed Dec 9, 2022
- Accession no.
- 0001209191-22-060586
- Filed
- Dec 9, 2022
- Trade date
- Dec 6, 2022
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.16K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glickman Mark ACIK 0001441461 | Officer (Co-Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | Common Stock | MOption exerciseAcquired | +1,734 | $0.00 | $0 | 1,734 | Direct | |
| Dec 6, 2022 | Common Stock | SSaleDisposed | −440 | $4.92 | −$2,164.8 | 1,294 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | Common Stock | MOption exerciseDisposed | −1,734 | $0.00 | $0 | 3,466 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.